Kiniksa Pharmaceuticals Ltd Technographics

Discover the latest software purchases and digital transformation initiatives being undertaken by Kiniksa Pharmaceuticals Ltd and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 215 Kiniksa Pharmaceuticals Ltd employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.

During our research, we have identified that Kiniksa Pharmaceuticals Ltd has purchased the following applications: GoDaddy for Application Hosting and Computing Services in 2015, New Relic APM for Application Performance Management in 2021, Microsoft 365 for Collaboration in 2015 and the related IT decision-makers and key stakeholders.

Our database provides customer insight and contextual information on which enterprise applications and software systems Kiniksa Pharmaceuticals Ltd is running and its propensity to invest more and deepen its relationship with GoDaddy , Microsoft , Amazon Web Services (AWS) or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.

We have been analyzing Kiniksa Pharmaceuticals Ltd revenues, which have grown to $38.5 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Kiniksa Pharmaceuticals Ltd intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.